Regulation of cell cycles is of key importance in human papillomavirus (HPV)- associated cervical carcinogenesis
Keywords:
Cervical cancers, Cell cycle, Human papillomavirus, Tumor suppressor genes, Histone deacetylaseAbstract
The rapid progress in molecular biology has allowed the identification of the genes involved in different functions of normal cells and has also improved our understanding of the mechanisms of human carcinogenesis. The human papillomavirus (HPV) is a small double-stranded DNA tumor virus and its genes can manipulate cell cycle control to promote viral persistence and replication. The E6 and E7 proteins of high-risk HPV bind to cell cycle regulatory proteins and interfere with both G1/S and G2/M cell cycle checkpoints much more effectively than the low-risk HPV. The difference between the ability of low and highrisk HPV types to induce immortalization and transformation may well lie in their abilities to interact with the various cell cycle components, resulting in the loss of multiple cell cycle checkpoints, which are important in host genome fidelity, thus potentially resulting in accumulation of genetic abnormalities. Cervical cancer is one of the leading malignancies in women worldwide, with substantial morbidity and mortality. According to current concepts, HPV is recognized as the single most important causal agent in the pathogenesis of this cancer. HPV infection clearly precedes the development of malignancy, while being regularly associated with cervical cancer precursor lesions (all grades of squamous intraepithelial lesions). HPV-infected low-grade squamous intraepithelial lesion (SIL) has three possible outcomes: a) it may regress; b) it can persist; or c) it can make a clinical progression to in situ or invasive carcinoma. It has been well established by prospective cohort studies that the spontaneous regression rate increases in parallel with follow-up duration. In contrast, the clinical progression of lesions usually takes place quite rapidly, i.e. during the first two years from diagnosis. The mechanisms responsible for this divergent clinical behavior of HPV-associated squamous intraepithelial lesions are largely unknown, but currently under intense study in different laboratories worldwide.
Downloads
References
Kastan MB. Molecular biology of cancer: the cell cycle. In: De Vita VT, Helman S, Rosenberg S, editors. Cancer: principles & practice of oncology. 5th ed. Philadelphia: Lippincott-Raven; 1997.p.121-33.
Syrjänen K. Human papillomaviruses in pathogenesis of lower genital tract neoplasia. In: Singer A, Monaghan JM, editors. Lower genital tract precancer. 2nd ed. Oxford: Blackwell Sci- ence; 2000.p.15-33.
Syrjänen SM, Syrjänen KJ. New concepts on the role of human papillomavirus in cell cycle regulation. Ann Med 1999;31(3):175-87.
dos Santos Oliveira L do H, Fernandez A de P, Xavier BL, Machado-Rodrigues E de V, Cavalcanti SM. Analysis of the p53 gene and papillomavirus detection in smears from cervical lesions. Sao Paulo Med J 2002;120(1):20-2.
IARC database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualization tools. 2nd ed, Lyon, France; 2001. Available from: http://www.iarc.fr/p53.
Brenna SM, Zeferino LC, Pinto GA, et al. P53 expression as a predictor of recurrence in cervical squamous cell carcinoma. Int J Gynecol Cancer 2002;12(3):299-303.
Makni H, Franco EL, Kaiano J, et al. P53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: ef- fect of inter-laboratory variation. Int J Cancer 2000;87(4):528-33.
Syrjänen KJ. Genital human papillomavirus infections and their associations with squamous cell cancer: reappraisal of the mor- phologic, epidemiologic and DNA data. In: Fenoglio-Preiser CM, Wolff M, Rilke F, editors. Progress in surgical pathology. USA: Fields & Wood; 1992.p.217-39.
Syrjänen KJ, Syrjänen SM. Molecular biology of papilloma- viruses. In: Syrjänen KJ, Syrjänen SM, editors. Papillomavirus infections in human pathology. New York: John Wiley & Sons; 2000.p.11-51.
Southern SA, Herrington CS. Disruptions of cell cycle control by human papillomaviruses with special reference to cervical carcinoma. Int J Gynecol Cancer 2000;10(4):263-74.
Murta EF, Souza MA, Araújo Júnior E, Adad SJ. Incidence of Gardnerella vaginalis, Candida sp. and human papillomavirus in cytological smears. São Paulo Med J 2000;118(4):105-8.
Nguyen DX, Westbrook TF, McCance DJ. Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest. J Virol 2002;76(2):619-32.
Juan LJ, Shia WJ, Chen MH, et al. Histone deacetylases spe- cifically down-regulate p53-dependent gene activation. J Biol Chem 2000;275(27):20436-43.
Ferenczy A, Franco E. Persistent human papillomavirus infec- tion and cervical neoplasia. Lancet Oncol 2002;3(1):11-6.
Ferenczy A, Franco E. Cervical-cancer screening beyond the year 2000. Lancet Oncol 2001;2(1):27-32.
